Subscriber Login
Recap IQ Series by Deloitte
DEAL builder
VALUATION analyzer
DEVELOPMENT optimizer
Recap Basic
Products
Consulting
Support & Training
News & Events
About
Subscribe
Allicense Conference
Allicense 2012
Date:
May 1-2, 2012
Location:
Palace Hotel, San Francisco
Early Bird Registration Open
Special Report
Report Shows mAbs Are Taking Longer to Develop
How U.S. Biotechnology Companies Pioneered the Path to Clinical, Regulatory and Market Success for Monoclonal Antibodies
Order Now
Special Report
What’s the Deal with Monoclonal Antibodies?
Part 2 of Deloitte Recap’s mAb report analyzes key drivers of deal value: technology type, therapeutic area, and stage of development
Order Now
White Papers and Case Studies
Case Study
Buy-Side Due Diligence
– How milestone payments & post-launch Effective Royalty Rates factor into a company’s value.
Register to Receive
White Paper
Innovative Strategies for Oncology Drug Development -
How biotech companies have won a growing share of oncology drug approvals.
Register to Receive
Home
|
Recap IQ by Deloitte
|
Recap Basic
|
Contact
|
Privacy Policy
|
Copyright ©
2012
Deloitte Recap LLC